ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 122 filers reported holding ACHILLION PHARMACEUTICALS IN in Q4 2018. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $2,698,000 | +6480.5% | 447,447 | +3839.1% | 0.00% | – |
| Q3 2019 | $41,000 | -47.4% | 11,359 | -61.2% | 0.00% | – |
| Q2 2019 | $78,000 | -19.6% | 29,273 | +11.5% | 0.00% | – |
| Q3 2018 | $97,000 | +4.3% | 26,265 | +29.5% | 0.00% | – |
| Q2 2017 | $93,000 | +31.0% | 20,280 | +19.7% | 0.00% | – |
| Q1 2017 | $71,000 | -78.5% | 16,943 | -60.3% | 0.00% | -100.0% |
| Q1 2016 | $330,000 | -26.5% | 42,728 | +2.7% | 0.00% | -50.0% |
| Q4 2015 | $449,000 | -70.1% | 41,620 | -75.5% | 0.00% | -80.0% |
| Q2 2015 | $1,503,000 | +126.4% | 169,633 | +213.0% | 0.01% | +100.0% |
| Q4 2014 | $664,000 | +118.4% | 54,200 | +78.0% | 0.01% | +66.7% |
| Q3 2014 | $304,000 | – | 30,446 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 13,633,220 | $57,396,000 | 7.04% |
| HealthInvest Partners AB | 497,807 | $2,096,000 | 3.21% |
| BVF INC/IL | 3,285,400 | $13,832,000 | 2.35% |
| EMORY UNIVERSITY | 486,438 | $2,048,000 | 1.93% |
| Marcus Capital, LLC | 69,400 | $1,751,000 | 1.63% |
| DAFNA Capital Management LLC | 196,500 | $827,000 | 0.70% |
| Orbimed Advisors | 13,107,200 | $55,181,000 | 0.62% |
| Rock Springs Capital Management LP | 1,500,000 | $6,315,000 | 0.36% |
| Spark Investment Management LLC | 710,100 | $2,989,000 | 0.19% |
| TURNER INVESTMENTS LLC | 65,420 | $275,000 | 0.18% |